Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$64.57
Market cap
$219M
P/E Ratio
15.12
Dividend/share
$1.2
EPS
$4.27
Enterprise value
$130.84M
Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized
Highlights
UTMD's P/E is 31% below its 5-year quarterly average of 22.0 and 7% below its last 4 quarters average of 16.3
Utah Medical Products's quick ratio has increased by 22% YoY and by 14% from the previous quarter
The gross profit has declined by 17% year-on-year and by 6% since the previous quarter
UTMD's revenue is down by 14% year-on-year and by 5% since the previous quarter
Key stats
What are the main financial stats of UTMD
Market
Valuations
Earnings
Shares outstanding
3.39M
Market cap
$219M
Enterprise value
$130.84M
Price to earnings (P/E)
15.12
Price to book (P/B)
1.81
Price to sales (P/S)
5.09
EV/EBIT
7.19
EV/EBITDA
6.13
EV/Sales
2.97
Revenue
$44.08M
EBIT
$18.21M
EBITDA
$21.36M
Free cash flow
$16.94M
Per share
Balance sheet
Liquidity
EPS
$4.27
Free cash flow per share
$4.87
Book value per share
$35.72
Revenue per share
$12.67
TBVPS
$32.22
Total assets
$129.69M
Total liabilities
$5.5M
Debt
$299,000
Equity
$124.2M
Working capital
$98.22M
Debt to equity
0
Current ratio
29.59
Quick ratio
26.83
Net debt/EBITDA
-4.13
Margins
Efficiency
Dividend
EBITDA margin
48.5%
Gross margin
58.8%
Net margin
34.6%
Operating margin
33.1%
Return on assets
11.5%
Return on equity
12.1%
Return on invested capital
93.3%
Return on capital employed
14.4%
Return on sales
41.3%
Dividend yield
1.86%
DPS
$1.2
Payout ratio
28.1%
UTMD stock price
How has the Utah Medical Products stock price performed over time
Intraday
0.61%
1 week
-2.93%
1 month
-1.82%
1 year
-22.53%
YTD
-23.33%
QTD
-3.5%
Financial performance
How have Utah Medical Products's revenue and profit performed over time
Revenue
$44.08M
Gross profit
$25.92M
Operating income
$14.61M
Net income
$15.26M
Gross margin
58.8%
Net margin
34.6%
The operating income has contracted by 18% YoY and by 4.1% from the previous quarter
The gross profit has declined by 17% year-on-year and by 6% since the previous quarter
UTMD's revenue is down by 14% year-on-year and by 5% since the previous quarter
UTMD's net income is down by 10% YoY and by 2.4% from the previous quarter
Growth
What is Utah Medical Products's growth rate over time
Valuation
What is Utah Medical Products stock price valuation
P/E
15.12
P/B
1.81
P/S
5.09
EV/EBIT
7.19
EV/EBITDA
6.13
EV/Sales
2.97
UTMD's P/E is 31% below its 5-year quarterly average of 22.0 and 7% below its last 4 quarters average of 16.3
UTMD's EPS is down by 8% year-on-year
UTMD's price to book (P/B) is 38% lower than its 5-year quarterly average of 2.9 and 10% lower than its last 4 quarters average of 2.0
The stock's P/S is 23% below its 5-year quarterly average of 6.6 and 6% below its last 4 quarters average of 5.4
UTMD's revenue is down by 14% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is Utah Medical Products business performance
UTMD's ROE is down by 15% YoY and by 2.4% from the previous quarter
Utah Medical Products's return on assets has decreased by 13% YoY
Utah Medical Products's ROIC has decreased by 12% YoY and by 3.6% from the previous quarter
UTMD's ROS is up by 3% year-on-year and by 2.2% since the previous quarter
Dividends
What is UTMD's dividend history
DPS
$1.2
Dividend yield
1.86%
Payout ratio
28.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Utah Medical Products financials performed over time
Utah Medical Products's total liabilities has decreased by 27% YoY and by 8% QoQ
Utah Medical Products's quick ratio has increased by 22% YoY and by 14% from the previous quarter
The debt is 100% lower than the equity
The debt is up by 9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.